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Abstract
Background: Testicular germ cell tumours are the most frequent cancer of young men with an increasing incidence all over
the world. Pathogenesis and reasons of this increase remain unknown but epidemiological and clinical data have suggested
that fetal exposure to environmental endocrine disruptors (EEDs) with estrogenic effects, could participate to testicular
germ cell carcinogenesis. However, these EEDs (like bisphenol A) are often weak ligands for classical nuclear estrogen
receptors. Several research groups recently showed that the non classical membrane G-protein coupled estrogen receptor
(GPER/GPR30) mediates the effects of estrogens and several xenoestrogens through rapid non genomic activation of signal
transduction pathways in various human estrogen dependent cancer cells (breast, ovary, endometrium). The aim of this
study was to demonstrate that GPER was overexpressed in testicular tumours and was able to trigger JKT-1 seminoma cell
proliferation.
Results: We report here for the first time a complete morphological and functional characterization of GPER in normal and
malignant human testicular germ cells. In normal adult human testes, GPER was expressed by somatic (Sertoli cells) and
germ cells (spermatogonia and spermatocytes). GPER was exclusively overexpressed in seminomas, the most frequent
testicular germ cell cancer, localized at the cell membrane and triggered a proliferative effect on JKT-1 cells in vitro, which
was completely abolished by G15 (a GPER selective antagonist) and by siRNA invalidation.
Conclusion: These results demonstrate that GPER is expressed by human normal adult testicular germ cells, specifically
overexpressed in seminoma tumours and able to trigger seminoma cell proliferation in vitro. It should therefore be
considered rather than classical ERs when xeno-estrogens or other endocrine disruptors are assessed in testicular germ cell
cancers. It may also represent a prognosis marker and/or a therapeutic target for seminomas.
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Introduction
Testicular germ cell cancer is the most frequent cancer
occurring in young men and originates from transformed
gonocytes or undifferentiated spermatogonia [1], which respec-
tively derived from foetal germ cells and adult germ stem cells.
Seminomas are the most frequent (50–70%) testicular germ cell
tumours. Clinical and experimental studies suggested that
oestrogens, the archetype of female hormones, participate in the
physiological and pathological control of male germ cell
proliferation [2,3]. However, the physiological role of oestrogens
during spermatogenesis and the molecular mechanisms by which
they regulate germ cell proliferation remain to be elucidated.
Identifying these mechanisms is important because foetal exposure
to environmental oestrogens is held responsible for the increasing
incidence of male infertility and testicular cancer [1,4], which stem
from impaired and excessive germ cell proliferation, respectively.
Since several years, we have been investigating the role of
oestrogens during germ cell proliferation using a human
seminoma cell line, JKT-1 [5] which express germ stem cell
markers [6]. Using JKT-1 cells, we showed that 17b-estradiol (E2)
inhibits in vitro cell proliferation through an oestrogen receptor
(ER)b-dependent mechanism [7]. In contrast, under the above
mentioned conditions, we also showed that E2 coupled to BSA
(E2-BSA), an impermeable E2 conjugate, stimulates in vitro JKT-1
cell proliferation by activating ERK1/2 and protein kinase A
through a membrane GPCR unrelated to classical ERs [8].
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tGPR30, an orphan GPCR, mediates the E2-induced prolifer-
ative effects in an ER-negative SKBr3 breast cancer cell line [9]. It
has recently been renamed as G protein-coupled oestrogen
receptor (GPER) (HUGO & MGI Databases). GPER is widely
expressed in various cell types and cancer cell lines [10,11] and is
overexpressed in endometrial cancers, aggressive breast cancers
and ovarian cancers [12–14]. Although the actual physiological
ligand of GPER remains unknown, we considered that it could be
a good candidate for mediating the proliferative effect of E2-BSA
[8] and of some xeno-oestrogens such as bisphenol A, which are
able in vitro to stimulate seminoma cell proliferation [6,15]. We
aimed to investigate GPER expression in normal and malignant
human testicular germ cells (tumours and JKT-1 cell line) and its
ability to trigger in vitro seminoma cell proliferation.
Materials and Methods
Cell culture
The JKT-1 cell line, a kind gift from Dr. Kinugawa, was
established from a human pure testicular seminoma developed from
the testis of a 40-yr-old man [5]. It was recently verified that the
JKT-1 cells maintained in our laboratory still expressed specific
embryonic stem cell markers [6]. The JKT-1 cells were maintained
in DMEM (InvitrogenH, Carlsbad, CA, USA) supplemented with
2% sodium pyruvate and 10% FBS (InvitrogenH) in a humidified
5% CO2 atmosphere at 37uC. The NCCIT cell line was developed
from a human testicular embryonic carcinoma and obtained from
the American Type Culture Collection (Manassas, VA, USA).
These TGCT adherent cells were grown in RPMI-1640 medium
(InvitrogenH) supplemented with 15% FBS and were maintained in
a humidified 5% CO2 atmosphere at 37uC. The 42GPA9 murine
Sertoli cell line was maintained in DMEM supplemented with 2%
sodium pyruvate and 10% FBS in a humidified 5% CO2
atmosphere at 32uC [16]. The mouse spermatogonial GC-1 cell
line with specific features common to type B spermatogonia was
maintainedinDMEMsupplementedwith 10%FBSinahumidified
5% CO2 atmosphere at 37uC.
Immunocytochemical and immunohistochemical
procedures
The cells were seeded in six-well plates (10
6 cells/well). After
48 h, the cells were washed and oestrogen starved overnight in
phenol red-free DMEM (InvitrogenH) supplemented with 1%
charcoal-stripped FBS. The cells were then exposed to FITC-
labelled E2-BSA (Sigma-AldrichH, St. Louis, MO, USA) for 1 h at
room temperature, fixed in 4% paraformaldehyde at room
temperature, washed twice in PBS and once in 50 mM PBS/
NH4Cl for 5 min at room temperature before being saturated in
PBS/0.1% Triton X-100 for 20 min. GPER and ERb were
detected using goat anti-GPER Ab (Santa Cruz BiotechnologyH,
Santa Cruz, CA, USA) and rabbit anti-ERb Ab (Santa Cruz
BiotechnologyH), respectively. After three washes in PBS, these
Abs were detected using anti-goat-Rhodamine Red
TM-X-conju-
gated Ab (1:50 in PBS with 5% goat serum; Jackson ImmunoR-
esearchH Laboratories Inc., West Grove, PA, USA) and anti-
rabbit-cyanine 5-labelled Ab (1:50 in PBS; Jackson ImmunoR-
esearchH Laboratories), respectively. The nuclei were stained with
Hoescht 33258 (blue; Molecular ProbesH, Eugene, OR, USA).
Control and tumoural human testes were collected from
patients of the Department of Urology of the Universitary
Hospital of Nice. This study was approved by the ethics committee
of this hospital. A written informed consent approved by the ethics
committee, was obtained for each patient. The samples were
embedded in paraffin blocks, sectioned at 7 mm and mounted on
charged glass slides. All immunostaining procedures were
performed after the sections were baked dry, de-waxed using
xylene substitute and rehydrated in a graded ethanol series (100%,
90%, 70% and 50%). Testis sections were washed with PBS for
5 min and heated at 90uC for 5 min in pre-heated citrate buffer.
The slides were then incubated with rabbit anti-GPER Ab (1:20;
Santa Cruz BiotechnologyH) in PBS, 5% FBS, 0.2% gelatin for 1 h
at room temperature and subsequently at 4uC overnight.
Coverslips were then incubated with Texas Red
TM-conjugated
donkey anti-rabbit Ab (1:30 in PBS; Amersham, Piscataway, NJ,
USA) for 2 h at room temperature before the nuclei were stained
with Hoescht 33258. In order to specifically identify Sertoli cells in
seminiferous tubules, a mouse monoclonal anti-vimentin clone V9
Ab (DakoH Denmark A/S, Glostrup, Denmark) was used.
Seminoma cells were identified on tumoural sections by using a
mouse monoclonal antibody against placental alkaline phospha-
tase (Thermo Fishert ScientificH, Fremont, CA, USA). Image
acquisition and analysis were performed on C3M (or MicorBio)
Cell Imaging Facility sections using a confocal laser scanning
microscope (LSM 510 META; oil immersion lens Zeiss Plan-
Neofluar; Carl ZeissH AG, Jena, Germany).
Cell proliferation assay
After 48 h, the JKT-1 cells were washed and oestrogen starved
overnight in phenol red-free DMEM supplemented with 1%
charcoal-stripped FBS. We then added E2 (Sigma-AldrichH),
freshly prepared E2-BSA (Sigma-AldrichH) devoid of free E2,
which is removed by filtration, ICI-182,780 (fulvestrant; Falso-
dexH, AstraZeneca, Wilmington, DE, USA), G1 (CalbiochemH,
Merck KGaA, Darmstadt, Germany), G15 (kindly supplied by Dr
Eric R. Prossnitz) [17] or ethanol (as a vehicle control) at 10
29 M
concentration [8,18] and incubated them for 24 h. We harvested
the cells using trypsin and counted them using the Vi-CELL
software (Beckman Coulter, Fullerton, CA, USA). Results are
expressed as percentages of variation compared with the control.
GPER silencing
The JKT-1 cells were transfected using the HiPerFect reagent
(Qiagen Inc., Valencia, CA, USA) with 50 nM GPER siRNA (sense
GGCUCUACAUUGAGCACAAtt; antisense UUCUGCUCAAU-
GUACAGCCtc; product no. s6053; AmbionH, Carlsbad, CA, USA)
or control siRNA, according to the manufacturer’s instructions. After
72-h culture, the cells were switched to phenol red-free DMEM
supplemented with 1% charcoal-stripped FBS and incubated for 24 h
with E2 or E2-BSA at 10
29 M concentration before being harvested
and counted using the Vi-CELL software. Results are expressed as
percentages of variation compared with the control.
Western blotting
The cells were grown in 10-cm dishes at a density of 4.9610
6
cells per dish. After 48 h, the cells were washed with PBS, and the
cell pellets were lysed in ice-cold lysis buffer Brij96/Nonidet P-40
(50 mM Tris HCl [pH 7.5], 1% Nonidet P-40, 1% Brij96 [FlukaH
AG, Buchs, Switzerland], 1 mM Na3VO4,1 0m Mb-glycerophos-
phate, 10 mM NaF, 2 mM EDTA and protease inhibitors
[Complete
TM; Roche Diagnostics, Indianapolis, IN, USA]). The
lysates were sonicated twice for 7 s on ice and centrifuged for
15 min at 14,000 rpm.
Control and malignant human testes were collected from
patients who underwent orchidectomy for TGCT [seminoma
(n=8) and non-seminoma (n=7)] and who gave their informed
consent. In each case, both tumoural and apparent normal
peritumoural tissues were isolated. This method excludes inter-
individual variations of GPER expression as each patient
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before being ground in cold Tris (10 mM, pH 7.4) containing
protease inhibitors.
Protein concentrations of the cell and tissue lysates were
determined by the Bradford method. Equal amounts of the whole
protein extract were resolved on a 12% SDS-polyacrylamide gel.
The proteins were transferred to a polyvinylidene difluoride
membrane (Immobilon P; Millipore
TM, Billerica, MA, USA),
probed with anti-GPER Ab (Santa Cruz BiotechnologyH) and
detected using HRP-linked secondary Ab and the ECL System
(GE HealthcareH, Chalfont St. Giles, UK). After the blots were
stripped, we verified equal loading of the protein by reprobing the
same blots with anti-actin Ab (Cell Signaling TechnologyH,
Danvers, MA, USA). All experiments were performed in triplicate
and the blots shown are representative.
RNA extraction and cDNA synthesis (reverse transcription
and real-time PCR)
Total RNA was extracted using TRIzol and processed using the
RNeasy Mini Kit (Qiagen Inc), according to the manufacturer’s
instructions. The amount of RNA was estimated by spectropho-
tometry at 260 nm. Total cDNA was synthesized by reverse
transcription of 10 mg of total RNA using random hexanucleotides
as primers (50 mM) in the presence of dNTPs (100 mM) and
Moloney murine leukaemia virus RT (40 U/mL) during 1 h at
37uC, following the manufacturer’s protocol (High Capacity
cDNA Reverse Transcription Kit; Applied Biosystems
TM, Foster
City, CA, USA).
Expression of selected genes was quantified by real-time PCR
using the StepOnePlus
TM Sequence Detection System (Applied
Biosystems
TM), following the manufacturer’s instructions. The
gene-specific primers used for gper and b-actin, which was used as
a control gene to obtain normalized values (GenBank accession
no. NM_001039966 and NM_001101, respectively), were as
follows: 59-TCTAAACTGCGGTCAGATGTGGCT-39 (gper
forward) and 59-TGTGAAGAGTGCAAGGTGACCAGT-39
(gper reverse) and 59-TTGCTGATCCACATCTGCTG-39 (b-
actin forward) and 59-GACAGGATGCAGAAGGAGAT-39 (b-
actin reverse), respectively [19].
PCR amplification was performed according to the manufac-
turer’s instructions by first heating the mixture at 95uC for 10 min,
followed by 55 cycles consisting of two steps: denaturation at 95uC
for 30 s, annealing and extension at 60uC for 60 s and then a final
cycle of three steps (95uC for 15 s, 60uC for 60 s and 95uC for
15 s). The PCR product was electrophoresed on a 3% agarose gel
in 16 TAE buffer (50 mM Tris-HCl, pH 8.0; 20 mM sodium
acetate and 2 mM EDTA) and stained with the SYBRH Safe DNA
gel stain (InvitrogenH). All experiments were performed in
triplicate and the data shown are representative.
Statistical analysis
All data were analysed using the StatViewH5 software (SAS
Institute Inc., Cary, NC, USA). Results of the cell count and
densitometric analysis are expressed as percentages of variation
compared with the control. A non-parametric Mann–Whitney U
test was used for statistical analysis. All probabilities were two-
sided and P,0.05 was considered statistically significant.
Results
GPER immunolocalization in normal and tumoural testes
Human testicular tissues were studied by immunofluorescence
to determine whether GPER was expressed in normal testis and
seminomas. Both normal and tumoural testes showed an intense
staining for GPER. In normal testis, GPER was localized in
seminiferous tubules (in Sertoli cells and in pre- and post-meiotic
germ cells) and also in Leydig cells. In seminoma, tumoural cells,
which were recognized by their size and specific PLAP-staining,
showed an intense staining for GPER (Figure 1).
In the JKT-1 cells, the GPER protein was identified by
membranous and cytoplasmic staining, whereas classical ERb had
an intracytoplasmic and nuclear localization without co-localiza-
tion with GPER (Figure 2). E2-BSA-FITC was also identified at
the JKT-1 cell membrane but not testosterone-BSA-FITC used as
negative control (data not shown). The colocalization of GPER and
E2-BSA at the JKT-1 cell membrane supported the notion that
GPER could bind E2-BSA and could be a good candidate to
mediate its proliferative effect previously reported in these cells [8].
GPER expression in tumoural human cell lines and testis
Using Western blotting, we compared the expression of GPER
between tumoural and normal tissues (i.e. non-tumoural tissue
from the same testis obtained during orchidectomy). Seminomas
showed significantly higher GPER protein expression than normal
peri-tumoural tissues (n=8; P=0.03; Figure 3). No significant
difference was observed between non-seminomas and normal peri-
tumoural tissues (n=7; P=0.65). These results were confirmed by
analysing mRNA levels by RT-PCR, which revealed significantly
higher GPER mRNA levels only in seminomas (P=0.004) but not
in non-seminomas (P=0.60), compared to normal peri-tumoural
tissues.
Analysis of mRNA by RT-PCR revealed that both JKT-1
(seminoma) and NCCIT (choriocarcinoma) cells expressed GPER.
These results were confirmed by Western blotting, which revealed
the expected 42-kDa band for the GPER protein (Figure S1). The
JKT-1 cells showed significantly higher GPER protein levels than
the NCCIT cells (P,0.05), whereas GPER mRNA expression was
higher in the NCCIT cells, suggesting post-translational regulation
of GPER expression in these cells.
E2-BSA stimulates JKT-1 cell proliferation by interacting
with GPER
After 24-h exposure at a physiological intratesticular concen-
tration of 10
29 M, E2 induced a significant decrease in cell
proliferation whereas E2-BSA at the same concentration stimu-
lated JKT-1 cell proliferation (Figure 4); testosterone-BSA, at the
same concentration, had no effect on JKT-1 cell proliferation (data
not shown) [8]. As we previously reported that this E2-BSA specific
effect was not inhibited by ICI-182,780, a pure ER antagonist, but
was reversed by Pertussis toxin, a G protein inhibitor [8], we
hypothesize that E2-BSA directly interacted with GPER to induce
JKT-1 cell proliferation. G1, a GPER-selective agonist, repro-
duced the same proliferative effect as that observed with E2-BSA.
G15, a GPER-selective antagonist, had no effect alone on JKT-1
cell proliferation but completely neutralized the E2-BSA-induced
proliferative effect (Figure 4). To confirm the role of GPER in E2-
BSA signalling, we performed GPER silencing in the JKT-1 cells
using GPER siRNA, which led to a 98% GPER silencing
confirmed by Western blotting (Figure 5) and RT-PCR (data not
shown). Whereas transfection with control siRNA had no effect on
JKT-1 cell proliferation after incubation with E2 and E2-BSA (data
not shown), GPER silencing had no effect on proliferation of the
JKT-1 cells incubated with E2 but it completely neutralized the
E2-BSA-induced proliferative effect, similar to co-incubation with
G15, confirming that GPER mediated the effects of E2-BSA on
JKT-1 cell proliferation (Figure 5). One may notice that the
inhibition of the proliferative effect of E2-BSA obtained by G15
(Figure 4) and GPER siRNA (Figure 5) was in both cases
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free E2 was likely involved as tested by addition with ICI (data not
shown).
Discussion
Several research groups have recently shown that GPER
(GPR30), an orphan GPCR with no evident physiological ligand,
mediates a rapid E2-dependent activation of signal transduction
pathways in various human estrogen-dependent cancer cells
(breast, ovary and endometrium) and displays E2 binding typical
of a membrane oestrogen receptor [20–23]. We report here for the
first time a characterization of GPER in normal and malignant
human testicular germ cells. GPER was overexpressed in
seminomas, was localized at the membrane of seminoma cells
and was able to mediate the promotive effect on seminoma cell
proliferation observed in vitro with E2-BSA.
GPER was expressed by somatic and germ cells in normal adult
human testes. In seminiferous tubules, Sertoli cells were stained for
GPER, similar to the adult mouse Sertoli cell line 42GPA9
previously established in our laboratory [24], and as already
reported in Zebrafish [25] and primary immature rat Sertoli cells
[26]. We found that spermatogonia and spermatocytes expressed
GPER while amazingly Rago et al. [27] reported a negative
staining in human germ cells, likely due to use of abnormal
granulomatous testes [27]. Moreover, our results are in agreement
Figure 1. Immunofluorescence analysis of GPER expression in normal human testis and seminoma. GPER was expressed (red
fluorescence) in normal testis both in the interstitial compartment (white arrows) and in seminiferous tubules (B, C) as opposed to negative control
(A). In order to specifically identify Sertoli cells in seminiferous tubules, a mouse monoclonal anti-vimentin clone V9 Ab (green fluorescence; DakoH
Denmark A/S, Glostrup, Denmark) was used (D). Double staining (E) allowed identifying GPER expression both in germinal and Sertoli cells (yellow
fluorescence [merge]). GPER was also expressed (red fluorescence) in seminoma cells (F), which were identified on a tumoural section (G) by using a
mouse monoclonal antibody against placental alkaline phosphatase (green fluorescence; Thermo Fisher ScientificH, Fremont, CA, USA). In all sections,
cell nuclei were stained by Hoechst 33258. Human MCF-7 breast cancer cells have been shown as positive control (window in B). Magnification:640
(A, B, D, E, F); 663 (C, G).
doi:10.1371/journal.pone.0034672.g001
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[28] and as reported in adult Zebrafish, Croaker and rat testicular
germ cells [25,29–31]. Thus, these data illustrate the wide
conservation of GPER but don’t assume the precise role of GPER
in testicular germ cells differentiation and proliferation. Although
male GPER KO mice (Artemis and Deltagen) are not infertile, their
precise gonadal phenotype remains unexplored [32]. In fact, it is
possible that this orphan GPCR may only interfere with oestrogen
and/or xeno-oestrogen activation during normal and/or patho-
logical regulation of germ cell proliferation and apoptosis, as
shown using G1 in rat pachytene spermatocytes and round
spermatids [31] and in human seminoma cells in our study.
GPER is a G protein-coupled seven transmembrane spanning
receptor that induces signalling through the Gs or Gi protein
[13,22,32,33], strongly suggesting the plasma membrane as
GPER’s site of action. However, the precise location of GPER
remains controversial [10,34,35] as GPER is localized at the
plasma membrane of different targeted and transfected cells [34]
but is expressed predominantly in the endoplasmic reticulum in
other reports [10,11]. One explanation could be the different
antibodies used, which triggered different epitopes (intra- or
extracytoplasmic) and/or cell trafficking of the protein, which is
described as highly unusual in human embryonic kidney HEK-
293 cells with an accumulation in the peri-nuclear space after
endocytosis from the plasma membrane [34]. It could also be cell
model dependent. Similar to that in HEK-293 cells, we found
double localization of GPER at the membrane and in the
cytoplasm in JKT-1 seminoma cells. Moreover, membrane
localization of GPER was supported by its co-localization with
E2-BSA-FITC, which does not cross the membrane, and its ability
to trigger a very rapid signal transduction induced by E2-BSA, a
membrane impermeable estrogen [8]. Phosphorylation of extra-
cellular regulated kinases and the cAMP response element-binding
protein occurred as soon as 5 to 15 min [8] and was reversed by
pertussis toxin, a G protein inhibitor [8].
In 2011, both Franco et al. [36] and Rago et al. [27] showed by
immunohistochemistry that GPER was present in testicular germ
cell tumours, including seminoma. Our study confirmed this
expression and demonstrated that GPER was overexpressed in
seminomas but not in non seminoma tumours by using a robust
quantitative approach of mRNAs and proteins levels by Q-PCR
and Western blotting related to b-actin, considered as a house-
keeping gene, and compared with the peri-tumoural normal
testicular tissue for each patient. Eventhough some abnormal
expression could be already observed in peritumoural tissues, this
method excludes inter-individual variations of GPER expression
as each patient represents its own control. This overexpression was
also confirmed by comparison between JKT-1 seminoma cells and
NCCIT choriocarcinoma cells.
GPER overexpression has been linked to the development of
advanced breast cancer [12], high-grade endometrial tumours
[13] and poor prognosis for ovarian cancer [14]. GPER
overexpression in seminomas may also represent a prognosis
factor for testicular germ cell tumours and perhaps a potential
therapeutic target as suggested by the result obtained with a
GPER-specific antagonist [17]. These different points are now
under investigation in our laboratory.
The precise mechanisms leading to such a GPER overexpres-
sion in seminomas need investigation. In a recent study, three
GPER SNPs were correlated with aggressive breast cancers [37];
involvement of GPER SNPs in human testicular germ cell cancers
is now under verification in our laboratory. Another explanation
Figure 2. Immunolocalization of GPER in JKT-1 seminoma cells. In JKT-1 cells, GPER (red fluorescence) had both a membranous and
intracytoplasmic perinuclear localization (A), whereas the classical oestrogen receptor ERb had an intracytoplasmic perinuclear and nuclear
localization (B, blue fluorescence). E2-BSA, an impermeable E2 conjugate that does not cross the membrane, stained the cell membrane when
coupled to FITC (C, green fluorescence). By double staining (D), E2-BSA (green) and GPER (red) co-localized at the membrane (yellow [merge]); GPER
was also expressed in the cytoplasm (red). (A, B, C, D: magnification, 663).
doi:10.1371/journal.pone.0034672.g002
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gene promoter region considering that such epigenetic modifica-
tions are now largely described in cancer [38–40].
We have already reported that E2 is able to induce a suppressive
effect on JKT-1 cell proliferation [7]. This effect is completely
suppressed by a pure ER antagonist, which supports the role of
ERb, the only classical ER expressed in JKT-1 cells [7]. In JKT-1
cells, ERb and GPER did not co-localize but induced two opposite
pathways. E2, with a well-known high affinity for ERb but a low
reported affinity for GPER [22], inhibited cell proliferation likely
through ERb, as already described for other oestrogen-dependent
cancers [41–44]. In contrast, G1, a selective GPER agonist, which
had a low affinity for ERb but a high affinity for GPER [45], and
E2-BSA, induced JKT-1 cell proliferation. It has been suggested in
some models [30] that GPER and ER (ERa/ERb) or a truncated
splice variant of ERs [46] could cooperate or cross-talk. ERa is not
express in JKT-1 [7] and ERb does not localize in the membrane
as shown by western blot analysis after subcellular fractioning [8].
Moreover ERb did not immunoprecipitated with caveolin, a
protein of the raft region in the cell membrane (data not shown).
Kang et al. [46] have reported in a human breast cancer model
that a truncated variant form of ERa, ER-a36, expressed in the
membrane, acted upstream of GPER and was even able to trigger
by itself a rapid non genomic estrogenic activation. While we
Figure 3. GPER expression in seminoma and non seminoma tumours. Quantitative analysis of GPER expression was performed by Western
blotting (A, B) and RT-PCR (C, D) in testicular germ cell tumours. b-actin was taken in each case as a house-keeping gene both in Western blotting and
RT-PCR. Relative expression of GPER mRNA and protein of the tumoural tissue was expressed as percentage of the value obtained in the normal peri-
tumoural testicular tissue of the same testis (represented as 100%). Histograms show the mean and standard deviation of the mRNA and protein
values for a group of 8 seminomas (A, C) and for a group of 7 non seminomas (B, D). Both mRNAs and protein values were significantly higher in
seminomas when compared to normal peri-tumoural testicular tissue (A, C). At the opposite, mRNAs and protein values were not different (P.0.05)
in non seminoma tumours when compared to normal peri-tumoural testicular tissue (B, D).
doi:10.1371/journal.pone.0034672.g003
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ERa or ERb in JKT-1 not recognized by our primers (PCR) or by
our antibodies (Western blotting) such as ER-a36, our data
support the direct implication of GPER. Using RNAi silencing
and G15, a selective GPER antagonist, we definitively demon-
strated the involvement of GPER in E2-BSA-induced JKT-1 cell
Figure 4. GPER triggers JKT-1 cell proliferation in vitro. JKT-1 cells were seeded in six-well plates (0,6610
6 cells/well). After 48 h, the JKT-1 cells
were washed and oestrogen starved overnight in phenol red-free DMEM supplemented with 1% charcoal-stripped FBS. Serum-deprived JKT-1 cells
were then incubated for 24 h with E2-BSA (1 nM), an impermeable E2-conjugate, which cannot thus interact with classical nuclear or cytoplasmic
estrogen receptors, after a pre-treatment with G15 (1 nM), a GPER antagonist, or ICI-182,780 (1 mM), a pure ER antagonist, or pertussis toxin (100 ng/
mL), a GPCR protein inhibitor. G1 (1 nM), a GPER-specific agonist, was used as a positive control. E2 at the same concentration (1 nM), which induces
an inhibitory effect on cell proliferation neutralized by ER antagonist ICI (1 mM), was used for comparison. Histograms represent percentages of
variation in the JKT-1 cell number compared with the control (0%), which was measured at 1,2610
6 cells/well after 24 hours of incubation in the
steroid-free medium with ethanol (10% of variation represent an increase or a decrease of 60 000 cells). All results are expressed as means 6 SEM of
three independents experiments. * P,0.01.
doi:10.1371/journal.pone.0034672.g004
Figure 5. Effects of GPER knockdown on E2 and E2-BSA-induced JKT-1 cell proliferation. (A) JKT-1 cells were transfected with 50 nM of
siRNA designed to knockdown GPER or with control siRNA. After 72-h incubation, proteins were extracted and subjected to Western blotting to
confirm the specific inhibitory activity of GPER siRNA after normalization with b-actin, which was evaluated as a house-keeping gene. (B) After 72 h
transfection with 50 nM of GPER siRNA or control siRNA, JKT-1 cells were incubated for 24 h with E2 (1 nM) or E2-BSA (1 nM). Histograms represent
the percentages of variation of the JKT-1 cell number compared to control without estrogens. Cell number was measured at 1,5610
6 cells/well after
24 hours of incubation in the steroid-free medium with ethanol (10% of variation representing an increase or a decrease of 90 000 cells). All results
are expressed as means 6 SEM of three independents experiments (*P,0.01).
doi:10.1371/journal.pone.0034672.g005
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e34672proliferation, similar to that shown recently by our laboratory for
bisphenol A, a plasticizer widely present in the environment and
considered as a xeno-oestrogen [15,47]. Although the physiolog-
ical role of exposure to estrogenic endocrine disruptors in testicular
carcinogenesis remains hypothetical, estrogen-dependency of this
male cancer should be assessed through both classical (ERb) and
non-classical (GPER) estrogen receptors.
Supporting Information
Figure S1 Expression of the G protein-coupled oestro-
gen receptor (GPER) in different human malignant
testicular germ cell lines. A: Histograms represent relative
GPER protein expression related to b-actin, which was taken as a
house-keeping gene, analyzed by western blot in different human
malignant testicular germ cell lines (JKT-1, a human pure
testicular seminoma cell line; NCCIT, a human testicular
embryonic carcinoma cell line). 42GPA9, a murine Sertoli cell
line, and GC-1, a spermatogonia type B murine cell line, represent
the positive controls. Results are expressed as means 6 SEM of
three different experiments. B: RT-PCR analysis of GPER in
JKT-1 and NCCIT cells. b-actin was evaluated as a house-keeping
gene.
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